Daniel M. Altmann mainly focuses on Immunology, Antigen, T cell, Epitope and Antibody. As part of the same scientific family, Daniel M. Altmann usually focuses on Immunology, concentrating on Cell biology and intersecting with HLA-DO. His Antigen study combines topics from a wide range of disciplines, such as Autoimmune disease, Insulitis, NOD mice, Multiple sclerosis and Antigen presentation.
Daniel M. Altmann interconnects Myelin basic protein, Genetically modified mouse and Interleukin 10 in the investigation of issues within Epitope. His Antibody research is multidisciplinary, relying on both Haematopoiesis, Stem cell, Myeloid, Cellular immunity and Lymphocyte. His studies in Immune system integrate themes in fields like Gastrointestinal tract and Rhesus macaque.
Daniel M. Altmann mostly deals with Immunology, Epitope, T cell, Antigen and Immune system. His study in Human leukocyte antigen, Acquired immune system, Immunity, Antibody and Autoimmunity is done as part of Immunology. His work carried out in the field of Epitope brings together such families of science as Myelin, Multiple sclerosis, Genetically modified mouse and Virology.
The various areas that Daniel M. Altmann examines in his T cell study include Experimental autoimmune encephalomyelitis, Cytotoxic T cell, CD8 and Coronavirus disease 2019. His biological study spans a wide range of topics, including T-cell receptor, Microbiology, Myelin basic protein, Cell biology and Antigen presentation. His work deals with themes such as Molecular biology and Antigen-presenting cell, which intersect with Antigen presentation.
Daniel M. Altmann mainly investigates Immunology, Immunity, Immune system, T cell and Coronavirus disease 2019. His is involved in several facets of Immunology study, as is seen by his studies on Acquired immune system, Antibody, Antigen, Human leukocyte antigen and Cytokine. His Antigen research incorporates themes from Tumor biology and Tumor immunology.
His Immunity research incorporates elements of Inflammation and Lung. Daniel M. Altmann studies Autoimmunity which is a part of Immune system. The concepts of his T cell study are interwoven with issues in Cancer immunology, Immunotherapy and Ovarian cancer.
His primary scientific interests are in Immunity, Immunology, Antibody, Virology and Coronavirus disease 2019. His research integrates issues of Melioidosis and Bronchiectasis in his study of Immunology. His study on Melioidosis also encompasses disciplines like
His research investigates the connection between Immune system and topics such as Bioinformatics that intersect with issues in Immunotherapy and Gut flora. His work on Severe acute respiratory syndrome coronavirus 2 and Betacoronavirus as part of general Coronavirus disease 2019 study is frequently linked to Need to know, therefore connecting diverse disciplines of science. Daniel M. Altmann usually deals with T cell and limits it to topics linked to Antigen and Neutralizing antibody, Titer and Asymptomatic.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Jason M. Brenchley;David A. Price;Timothy W. Schacker;Tedi E. Asher.
Nature Medicine (2006)
COTRANSFECTION OF ICAM-1 AND HLA-DR RECONSTITUTES HUMAN ANTIGEN-PRESENTING CELL FUNCTION IN MOUSE L CELLS
Daniel M. Altmann;Nancy Hogg;John Trowsdale;David Wilkinson.
Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors.
Martin Pette;Kyoko Fujita;David Wilkinson;Daniel M. Altmann.
Proceedings of the National Academy of Sciences of the United States of America (1990)
Control of Exposure to Mite Allergen and Allergen-Impermeable Bed Covers for Adults with Asthma
Ashley Woodcock;Louise Forster;Edward Matthews;Jeannett Martin.
The New England Journal of Medicine (2003)
The immunology of sepsis.
S Sriskandan;DM Altmann.
The Journal of Pathology (2008)
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals.
Charlotte Manisty;Ashley D Otter;Thomas A Treibel;Áine McKnight.
The Lancet (2021)
The experience of dying with dementia: a retrospective study
Mark McCARTHY;Julia Addington-Hall;Dan Altmann.
International Journal of Geriatric Psychiatry (1997)
An HLA-DR1 Transgene Confers Susceptibility to Collagen-induced Arthritis Elicited with Human Type II Collagen
Edward F. Rosloniec;David D. Brand;Linda K. Myers;Karen B. Whittington.
Journal of Experimental Medicine (1997)
Innate immunity in multiple sclerosis white matter lesions: expression of natural cytotoxicity triggering receptor 1 (NCR1).
Pascal F Durrenberger;Anna Ettorre;Fatemah Kamel;Louise V Webb.
Journal of Neuroinflammation (2012)
Herpes Simplex Virus Latency
T.J. Hill;D.M. Altmann;W.A. Blyth;D.A. Harbour.
Clinics in Dermatology (1984)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: